緒方 晴彦

Medicine & Life Sciences

1. Ulcerative Colitis 100%
2. Crohn Disease 48%
3. Capsule Endoscopy 38%
4. Inflammatory Bowel Diseases 32%
5. Colitis 23%
6. Endoscopy 23%
7. Colonoscopy 23%
8. Capsule Endoscopes 22%
9. Endoscopic Mucosal Resection 22%
10. Infliximab 19%
11. Mesalamine 18%
12. Stomach 15%
13. Colon 14%
14. Hemorrhage 14%
15. Mucous Membrane 13%
16. vedolizumab 13%
17. Single-Balloon Enteroscopy 12%
18. Therapeutics 11%
19. Japan 10%
20. Gastrointestinal Endoscopy 10%
21. Safety 10%
22. Indigo Carmine 10%
23. Balloon Enteroscopy 9%
24. Capsules 9%
25. Steroids 8%
26. Placebos 8%
27. Recurrence 8%
28. Adalimumab 8%
29. Confidence Intervals 7%
30. Feasibility Studies 7%
31. Genes 7%
32. Neoplasms 7%
33. Randomized Controlled Trials 7%
34. Surgical Instruments 7%
35. Pathologic Constriction 7%
36. rat TFF3 protein 6%
37. Prospective Studies 6%
38. Polyps 6%
39. Interleukin-7 6%
40. Ileum 6%
41. Inflammation 6%
42. Blood Component Removal 6%
43. Sigmoid Colon 6%
44. Stomach Neoplasms 6%
45. Epithelial Cells 6%
46. Endoscopic Hemostasis 5%
47. Tacrolimus 5%
48. Biopsy 5%
49. Ulcer 5%
50. Immunologic Factors 5%